After the c-KIT-positive and negative BMCs from AML patients were chosen (c-KIT-positive samples, n = 10; c-KIT-negative samples, n = 4), the c-KIT antigen expression was confirmed on BMCs of AML patients (Fig. 1B, Supplementary Table 1). This evidence concerns the gene KIT and acute myeloid leukemia.